Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 27;22(17):9280.
doi: 10.3390/ijms22179280.

Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells

Affiliations
Review

Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells

Hilal Arnouk et al. Int J Mol Sci. .

Abstract

Cripto-1 is an essential protein for human development that plays a key role in the early phase of gastrulation in the differentiation of an embryo as well as assists with wound healing processes. Importantly, Cripto-1 induces epithelial to mesenchymal transition to turn fixed epithelial cells into a more mobile mesenchymal phenotype through the downregulation of epithelial adhesion molecules such as E-cadherin, occludins, and claudins, and the upregulation of mesenchymal, mobile proteins, such as N-cadherin, Snail, and Slug. Consequently, Cripto-1's role in inducing EMT to promote cell motility is beneficial in embryogenesis, but detrimental in the formation, progression and metastasis of malignant tumors. Indeed, Cripto-1 is found to be upregulated in most cancers, such as breast, lung, gastrointestinal, hepatic, renal, cervical, ovarian, prostate, and skin cancers. Through its role in EMT, Cripto-1 can remodel cancer cells to enable them to travel through the extracellular matrix as well as blood and lymphatic vessels to metastasize to different organs. Additionally, Cripto-1 promotes the survival of cancer stem cells, which can lead to relapse in cancer patients.

Keywords: Cripto-1; EMT; biomarker; breast cancer; cancer stem cells; epithelial to mesenchymal transition; melanoma; metastasis; therapeutic target; tumor progression.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Epithelial to Mesenchymal Transition (EMT) and Mesenchymal to Epithelial Transition (MET).
Figure 2
Figure 2
Upregulated and Downregulated Proteins in EMT.

References

    1. Wang B., Yan J., Peng Z., Wang J., Liu S., Xie X., Ma X. Teratocarcinoma derived growth factor 1 (TDGF1) sequence variants in patients with congenital heart defect. Int. J. Cardiol. 2011;146:225–227. doi: 10.1016/j.ijcard.2009.08.046. - DOI - PubMed
    1. Morkel M., Huelsken J., Wakamiya M., Ding J., van de Wetering M., Clevers H., Taketo M.M., Behringer R.R., Shen M.M., Birchmeier W. Beta catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development. 2003;130:6283–6294. doi: 10.1242/dev.00859. - DOI - PubMed
    1. Parisi S., D’Andrea D., Lago C.T., Adamson E.D., Persico M.G., Minchiotti G. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J. Cell Biol. 2003;163:303–314. doi: 10.1083/jcb.200303010. - DOI - PMC - PubMed
    1. D’Aniello C., Lonardo E., Iaconis S., Guardiola O., Liguoro A.M., Liguori G.L., Autiero M., Carmeliet P., Minchiotti G. G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway. Circ. Res. 2009;105:231–238. doi: 10.1161/CIRCRESAHA.109.201186. - DOI - PubMed
    1. Schier A., Shen M. Nodal signalling in vertebrate development. Nature. 2000;403:385–389. doi: 10.1038/35000126. - DOI - PubMed

MeSH terms

Substances